Pila Pharma AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Apr '25 Apr 29, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Market Capitalization	82	102	38	50	109	-	Upgrade
Market Cap Growth	167.21%	167.21%	-23.60%	-54.48%	-	-	Upgrade
Enterprise Value	77	99	38	45	77	-	Upgrade
Last Close Price	3.02	3.75	1.60	3.10	6.64	-	Upgrade
PS Ratio	103.71	128.78	26.02	26.50	152.22	-	Upgrade
PB Ratio	15.57	19.33	5.72	5.23	3.61	-	Upgrade
P/TBV Ratio	19.58	24.31	8.45	7.91	4.05	-	Upgrade
EV/Sales Ratio	97.52	125.56	26.26	23.77	106.59	-	Upgrade
Debt / Equity Ratio	-	-	-	-	-	0.15	Upgrade
Asset Turnover	0.11	0.11	0.15	0.09	0.04	-	Upgrade
Quick Ratio	5.16	5.16	3.47	5.49	18.72	1.00	Upgrade
Current Ratio	5.21	5.21	3.48	5.59	18.81	1.05	Upgrade
Return on Equity (ROE)	-188.57%	-188.57%	-122.66%	-134.47%	-102.07%	-128.36%	Upgrade
Return on Assets (ROA)	-69.05%	-69.05%	-41.32%	-26.03%	-31.14%	-31.74%	Upgrade
Return on Capital (ROIC)	-85.02%	-85.02%	-49.36%	-27.90%	-33.83%	-37.13%	Upgrade
Earnings Yield	-13.72%	-11.05%	-26.08%	-53.74%	-15.72%	-	Upgrade
Buyback Yield / Dilution	-20.66%	-20.66%	-22.29%	-31.86%	-30.89%	-	Upgrade

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.